RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy.

Significance of monitoring vascular endothelial growth factor, monocyte chemoattractant protein-1 and Interleukin-8 in diabetic macular edema towards early identification of nonresponders to ranibizumab therapy.

Add to Collection
2021 Jun Others Fist_Author_Year_PM

Full Author : ['Xavier, Tessy', 'Pallikara, Swetha', 'Saji, Neha', 'Radhakrishnan, Natasha', 'Menon, Krishnakumar N', 'Pillai, Gopal S']
Journal Title : Indian journal of ophthalmology
Chapter : Section3
Journal Year : 2021
Cited by : Not Available

PURPOSE: Identification of nonresponders prior to anti-vascular endothelial growth factor (anti-VEGF) therapy would help in the judicious clinical management of diabetic macular edema (DME) patients. Thus, a systematic study was initiated to identify nonr.....

Keywords : ["monitor vascular endothelial growth factor monocyte chemoattractant", "diabetic macular edema towards early identification", "ranibizumab therapy", "significance", "nonresponder"]